Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(8/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(8/week)
News
United States
(492/week)
Manufacturing
(332/week)
Energy
(271/week)
Technology
(348/week)
Other Energy
(234/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
AbbVie
Feb 25, 2021
Allergan, an AbbVie Company, Submits New Drug Application for Investigational AGN-190584 for the Treatment of Presbyopia
Feb 24, 2021
HUMIRA® (adalimumab) Receives FDA Approval to Treat Pediatric Patients Living with Moderately to Severely Active Ulcerative Colitis
Feb 23, 2021
New REFRESH® DIGITAL Lubricant Eye Drops Tackle Eye Dryness Due to Everyday Screen Use
Feb 22, 2021
Second Phase 3 Induction Study Confirms Upadacitinib (RINVOQ(TM)) Improved Clinical, Endoscopic and Histologic Outcomes in Ulcerative Colitis Patients
Feb 19, 2021
AbbVie, Evolus, and Medytox Announce Resolution of Intellectual Property Litigation
Feb 18, 2021
AbbVie Declares Quarterly Dividend
Feb 03, 2021
AbbVie Reports Full-Year and Fourth-Quarter 2020 Financial Results
Jan 26, 2021
CoolSculpting® by Allergan Aesthetics Expands Body Contouring Portfolio With CoolSculpting® Elite
Jan 12, 2021
AbbVie to Host Fourth-Quarter and Full-Year 2020 Earnings Conference Call
Jan 12, 2021
Allergan Aesthetics Enters Into Option to Acquire Cypris Medical
Jan 07, 2021
Risankizumab (SKYRIZI®) Demonstrates Significant Improvements in Clinical Remission and Endoscopic Response in Two Phase 3 Induction Studies in Patients with Crohn's Disease
Jan 06, 2021
AbbVie to Present at the 39th Annual J.P. Morgan Healthcare Conference
Jan 05, 2021
Risankizumab (SKYRIZI®) Phase 3 Results Demonstrate Improvements in Disease Activity Across Joint and Skin Symptoms Among Psoriatic Arthritis Patients
Dec 23, 2020
IMBRUVICA® (ibrutinib) U.S. Prescribing Information Updated to Include Long-Term Data for Waldenström's Macroglobulinemia (WM)
Dec 11, 2020
CHMP Recommends the Approvals of RINVOQ(TM) (Upadacitinib) for the Treatment of Adults with Active Psoriatic Arthritis and Ankylosing Spondylitis
Dec 10, 2020
RINVOQ(TM) (upadacitinib) Achieved Superiority Versus DUPIXENT® (dupilumab) For Primary and All Ranked Secondary Endpoints in Phase 3b Head-to-Head Study in Adults with Atopic Dermatitis
Dec 09, 2020
Upadacitinib (RINVOQ(TM)) Meets Primary and All Ranked Secondary Endpoints in First Phase 3 Induction Study in Ulcerative Colitis
Dec 09, 2020
AbbVie Announces Partners in $50 Million Program to Promote Health and Education Equity in Underserved Black Communities
Dec 05, 2020
IMBRUVICA® (ibrutinib) Plus VENCLEXTA®/VENCLYXTO® (venetoclax) Combination Shows High Rates of Disease-Free Survival One Year Post-Treatment in Previously Untreated Patients with Chronic Lymphocytic Leukemia (CLL)
Dec 02, 2020
AbbVie and Frontier Medicines Establish Global Partnership to Discover and Develop Novel Therapies and E3 Degraders Against Difficult-to-Drug Targets
Page 1
››
Latest News
Apr 19, 2024
Small Wind Global Strategic Industry Report 2024-2030: Small Wind Turbines - A Real Blue-Sky Opportunity for...
Apr 19, 2024
Essential Utilities Names Natalie Chesko as New President of Aqua New Jersey
Apr 18, 2024
Black Bear Transmission Places Ozark Supply Access Project In-Service
Apr 18, 2024
NGS Simulates First-Ever Performance Demonstration of New Glazing Security Solution, 3M S2400
Apr 18, 2024
CLEAResult Releases 2023 Sustainability Report, Showcasing 133 Million Metric Tons of CO2 Averted Since 2003
Apr 18, 2024
TriMas Packaging Group to Exhibit at LUXE PACK New York and China Beauty Expo
Apr 18, 2024
Zero Motorcycles Launches Tesla Tap Mini: The Key to Expanded Charging Options
Apr 18, 2024
Ferguson plc: Publication of Registration Statement, Proxy Statement, Notice of Special Meeting and U.K....
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events